Publications by authors named "Christopher I Ho"

Claim this Profile
I
Inhibition of cardiovascular cell proliferation by angiotensin receptor blockers: are all molecules the same?
Stephen C Benson, Rumiko Iguchi, Christopher I Ho, Koichi Yamamoto, Theodore W Kurtz

J Hypertens· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of the first generation of dithiolane thiazolidinedione- and phenylacetic acid-based PPARgamma agonists.
Amar G Chittiboyina, Meenakshi S Venkatraman, Cassia S Mizuno, Prashant V Desai, Akshay Patny, Christopher I Ho

J Med Chem· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-Lipoic acid-based PPARgamma agonists for treating inflammatory skin diseases.
Meenakshi S Venkatraman, Amar Chittiboyina, Josef Meingassner, Christopher I Ho, James Varani

Arch Dermatol Res· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.
Stephen C Benson, Harrihar A Pershadsingh, Christopher I Ho, Amar Chittiboyina, Prashant Desai

Hypertension· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytes.
Narasimharao Bhagavathula, Kamalakar C Nerusu, Ashish Lal, Charles N Ellis, Amar Chittiboyina, Christopher I Ho

J Invest Dermatol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis